Positive Minimal Residual Disease By Multiparameter Flow Cytometry in 9 Months after Autologous Stem Cell Transplantation and High-Risk Cytogenetics Predict Poor Outcome in Multiple Myeloma

被引：0
|
作者：
Huang, Beihui
Li, Juan
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4532
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Monitoring of minimal residual disease in multiple myeloma after allogeneic stem cell transplantation:: flow cytometry versus PCR-based techniques
    Lioznov, MV
    Cortes-Dericks, L
    Schwartz, S
    Badbaran, A
    Fehse, B
    Zander, AR
    Kröger, N
    BONE MARROW TRANSPLANTATION, 2006, 37 : S145 - S146
  • [22] Prognostic impact of natural killer cell recovery on minimal residual disease after autologous stem cell transplantation in multiple myeloma
    Keruakous, Amany R.
    Asch, Adam
    Aljumaily, Raid
    Zhao, Daniel
    Yuen, Carrie
    TRANSPLANT IMMUNOLOGY, 2022, 71
  • [23] Comparison of Minimal Residual Disease Detection by Multiparameter Flow Cytometry, ASO-qPCR, Droplet Digital PCR, and Deep Sequencing in Patients with Multiple Myeloma Who Underwent Autologous Stem Cell Transplantation
    Takamatsu, Hiroyuki
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (10)
  • [24] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Yoshihiro
    Kurahashi, Shingo
    Imahashi, Nobuhiko
    Fukushima, Nobuaki
    Adachi, Tatsuya
    Kinoshita, Tomohiro
    Tsushita, Keitaro
    Miyamura, Koichi
    Naoe, Tomoki
    Sugiura, Isamu
    AMERICAN JOURNAL OF HEMATOLOGY, 2009, 84 (05) : 283 - 286
  • [25] Combinations of cytogenetics and international scoring system can predict poor prognosis in multiple myeloma after high-dose chemotherapy and autologous stem cell transplantation
    Inamoto, Y.
    Kurahashi, S.
    Fukushima, N.
    Imahashi, N.
    Murata, M.
    Tsushita, K.
    Miyamura, K.
    Kinoshita, T.
    Naoe, T.
    Kodera, Y.
    Sugiura, I.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S182 - S182
  • [26] Impact of Non High-Risk Chromosomal Abnormalities on the Outcome of Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
    Ahmed, Sairah
    Lin, Heather
    Baladandayuthapani, Veera
    Khan, Mubeen A.
    Lu, Gary
    Rondon, Gabriela
    Qureshi, Sofia
    Dinh, Yvonne T.
    Bashir, Qaiser
    Shah, Nina
    Parmar, Simrit
    Hosing, Chitra M.
    Popat, Uday
    Giralt, Sergio A.
    Orlowski, Robert Z.
    Shah, Jatin J.
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BLOOD, 2011, 118 (21) : 156 - 157
  • [27] AUTOLOGOUS BLOOD STEM-CELL TRANSPLANTATION IN HIGH-RISK MULTIPLE-MYELOMA
    REIFFERS, J
    MARIT, G
    BOIRON, JM
    BRITISH JOURNAL OF HAEMATOLOGY, 1989, 72 (02) : 296 - 297
  • [28] The Impact of Autologous Stem Cell Transplantation on the Genetics of High-Risk Relapsed Multiple Myeloma
    Shahin, Mohamed
    Pawlyn, Charlotte
    Weinhold, Niels
    Ashby, Timothy Cody
    Walker, Brian A.
    Wardell, Christopher P.
    Cairns, David
    Menzies, Tom
    Gregory, Walter Martin
    Kaiser, Martin F.
    Cook, Gordon
    Drayson, Mark T.
    Owen, Roger G.
    Jackson, Graham
    Davies, Faith E.
    Morgan, Gareth J.
    Jones, John R.
    BLOOD, 2022, 140 : 4232 - 4233
  • [29] Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis
    Hanqing Li
    Feng Li
    Xiaogang Zhou
    Jiangang Mei
    Ping Song
    Zhiming An
    Qian Zhao
    Xing Guo
    Xuli Wang
    Yongping Zhai
    Annals of Hematology, 2019, 98 : 1185 - 1195
  • [30] Achieving minimal residual disease-negative by multiparameter flow cytometry may ameliorate a poor prognosis in MM patients with high-risk cytogenetics: a retrospective single-center analysis
    Li, Hanqing
    Li, Feng
    Zhou, Xiaogang
    Mei, Jiangang
    Song, Ping
    An, Zhiming
    Zhao, Qian
    Guo, Xing
    Wang, Xuli
    Zhai, Yongping
    ANNALS OF HEMATOLOGY, 2019, 98 (05) : 1185 - 1195
12345